The most notable companies in this group are JPMorgan Chase & Co (NASDAQ:JPM), Johnson & Johnson (NASDAQ:JNJ), Merck & Co (NASDAQ:MRK), Pfizer (NASDAQ:PFE), ConocoPhillips (NASDAQ:COP), EOG Resources (NASDAQ:EOG).
The investment seeks to provide current income with growth of capital as a secondary objective.
The fund targets an allocation of approximately 45% equity securities and 55% fixed income investments, with the allocation generally varying by no more than +/-5%. The equity portion of the fund invests primarily in common stocks with a history of above-average dividends or expectations of increasing dividends. It may invest up to 20% of the fixed income portion of the portfolio in domestic non-investment grade debt.
The average market capitalization across the Hartford Balanced Income R4 MF is 183.56B. The market cap for tickers in the group ranges from 71.73B to 443.89B. JPM holds the highest valuation in this group at 443.89B. The lowest valued company is EOG at 71.73B.
The average weekly volume growth across all stocks in the Hartford Balanced Income R4 MF was -56%. For the same stocks of the MF, the average monthly volume growth was -53% and the average quarterly volume growth was -41%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 46
P/E Growth Rating: 52
Price Growth Rating: 48
SMR Rating: 41
Profit Risk Rating: 36
Seasonality Score: 17 (-100 ... +100)